It might sound like a concept from science fiction, but artificial intelligence is already facilitating the development process behind some pharmaceuticals. Hosted by: Michael Aranda SciShow has a ...

To this day, animal testing remains one of the most controversial issues in animal rights. Activists have been fighting ...

Backed with $82 million and led by two of BioMarin’s former executives, Mendra plans to acquire rare disease assets and use ...

The initiative could tackle the first-mover disadvantage some CDMOs believe deters early customers, but leaders at companies ...

For decades, discovery has relied on "brute force" mass-screening – testing thousands of random compounds hoping one will ...

The startup has partnered with Eli Lilly and enjoys the backing of some of Silicon Valley's most influential VCs.

An FDA draft guidance nixing the requirement for biosimilar manufacturers to conduct comparative efficacy studies may prove ...

For pet owners who dread how short a dog's life can be, a beef-flavored tablet could offer real hope for more time together.

Thermo Fisher Scientific is acquiring Clario for roughly $8.9 billion, a major move to boost its clinical research services.

Scientists have developed a new treatment strategy that could one day save the lives of children affected by aggressive brain ...

In Darwinian terms, survival isn’t a matter of being the biggest, the fastest, or the strongest of the species, but instead ...